MDS World Awareness Day is October 25. Knowledge can help patients and caregivers feel more prepared. Explore HealthTree’s MDS Guide and upcoming educational webinars. 👉 Learn more: htree.org/mdsguide #MDSAwareness #MDS #HealthTree

Thank you @MeeraMohanMD for hosting the HealthTree Houston Roundtable to teach patients about new tools like bispecific antibodies in myeloma and how they are changing the outcomes for NDMM and RRMM. Such amazing progress that is so good for patients. #mmsm

CAR T in myeloma is a personalized, living therapy, timing and eligibility matter, preparation is key and lasting responses are possible. @DrKrinaPatel of MDACC at the HealthTree Houston Roundtable. #mmsm

Patients can ask their doctor about CAR T eligibility. Am I a candidate? Do I need a referral to a CAR T center? Are there CAR T trials I should join? @DrKrinaPatel of MDACC at the HealthTree Houston Roundtable. #mmsm

Individualizing therapy in myeloma factors in genetics, frailty and comorbidities, patient outcomes, adapted treatment based on MRD status, toxicity, disease resistance, social factors and sequencing. Savari Yellqpragada, MD of MDACC. #mmsm

Frailty rather than age predicts outcomes in myeloma - Sarvari Yellqpragada, MD of MDACC at the Houston HealthTree Roundtable. Frail patients can limit induction, avoid transplant and de-escalate maintenance. #mmsm

“Assessing risk can be risky” says Bill Matsui, MD of MDACC. It’s statistical, not exact. Risk can change over time and each risk factor (genetics, disease stage, etc) may contribute differently for each myeloma patient. At the HealthTree Houston Roundtable #mmsm

Bill Matsui, MD of MD Anderson shares early precursor conditions and how newly diagnosed myeloma patients can find personalized care - today at the Houston HealthTree Roundtable. #mmsm

Join Dr. William G. Wierda, MD, PhD from MD Anderson for a live CLL CME on Nov. 17, 5–6 PM CT. Explore treatment strategies and shared decision-making for personalized care. activities.paradigmmc.com/14… @ParadigmMedCom @CllSociety #CME

Better data can drive better care and research. HealthTree’s Personal Health Record brings patient health information together to support personalized care and, with patient consent, advance research. htree.org/personalhealthreco… #HealthTree #PersonalHealthRecord

Could blood tests reduce the need for bone marrow biopsies in myeloma? 🩸 Blood based MRD testing is promising, but it still has limitations. Learn what patients should know. healthtree.org/leukemia+lymp… #MultipleMyeloma #MRD #MyelomaResearch #HealthTree

What does “cure” mean in multiple myeloma? At #IMS2026, Dr. Mohamad Mohty explains how newer therapies, sustained MRD negativity, imaging, and treatment-free remission are changing the conversation around cure. Watch the full conversation. youtu.be/AftPCq2jsdA #MultipleMyeloma #MyelomaResearch #HealthTree

A patient’s health story rarely lives in one hospital. HealthTree now has more than 7,900 hospital integrations across the United States, helping connect more of the information that makes up a patient’s health journey. A more complete health record can support personalized patient experiences while helping create richer data for research and clinical trial matching. The more complete the story, the more possibilities it can unlock. 👉 Learn more about connecting your records with HealthTree: healthtree.org/myeloma/perso… #HealthData #PersonalizedSupport #PatientCenteredCare #Research #PowerTheCure #HealthTree

Can AI help researchers capture better data from multiple myeloma patients? 💚 At IMS, an AI-assisted “Doctor in the Loop” workflow achieved 97.2% precision vs. 84.1% with manual extraction. Reviewers also missed 4.7x more data points when working manually. Better data can mean better insights for patients and research. #Myeloma #MultipleMyeloma #CancerResearch #IMS2026 #HealthTree

What does “cure” mean to you? At IMS 2026, Jenny Ahlstrom shared a patient perspective on the cure conversation in multiple myeloma. Now we want to hear from the myeloma community. What would a cure mean to you? 👉 Read the story and share your perspective in our short survey: healthtree.org/myeloma/news/… #MultipleMyeloma #Myeloma #PatientVoice #HealthTree

Can some patients with multiple myeloma stop treatment and remain in long-term remission? At #IMS2026, Dr. Zachary Avigan shares research on factors associated with durable remission and the potential for cure. Watch the interview. youtu.be/9Q9DegLWCas #MultipleMyeloma #MyelomaResearch #HealthTree @Zach_Avigan

What if there’s an option you haven’t discovered yet? HealthTree’s Clinical Trial Finder helps patients explore clinical trials that may match their diagnosis. Because you can’t consider an option if you don’t know it exists. Explore what’s possible: healthtree.org/myeloma/find-… #ClinicalTrials #BloodCancer #HealthTree